Product Information
- 4-[(Z)-(1-methylpiperidin-4-yl)iminomethyl]phenol
- 1-(4-Fluorobenzyl)-1-(1-Methylpiperidin-4-Yl)-3-[4-(2-Methylpropoxy)Benzyl]Urea
- 1-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea
- 1-[(4-Fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
- N-(4-Fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-[[4-(2-methylpropyloxy)phenyl]methyl]carbamide
- N-[(4-Fluorophenyl)methyl]-N-(1-methyl-4-piperidinyl)-N′-[[4-(2-methylpropoxy)phenyl]methyl]urea
- Nuplazid
- Urea, N-[(4-fluorophenyl)methyl]-N-(1-methyl-4-piperidinyl)-N′-[[4-(2-methylpropoxy)phenyl]methyl]-
Applications 4-[(E)-(1-methyl-4-piperidyl)iminomethyl]phenol is an impurity of Pimavanserin (P441800), which is a drug used in the treatment of Parkinson’s disease and psychosis.
References Snigdha, S., et al.: J. Pharmacol. Exper. Ther., 332, 622 (2010), Meltzer, H., et al.: Neuropsychopharmacol., 35, 881 (2010)
Chemical properties
Technical inquiry about: TR-E521543 4-[(E)-(1-methyl-4-piperidyl)iminomethyl]phenol
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.